Skip to main content
. 2023 Jan 21;15(2):364. doi: 10.3390/pharmaceutics15020364

Figure 3.

Figure 3

Schematic illustration of the molecular mechanisms which can be targeted to increase SLC drug transporter expression on cell plasma membrane. Nucleus receptor (1), DNA de-methylation (2) and histone de-acetylation (3) mediated increase in transporter expression. Ubiquitination inhibition mediated reduction of transporter recycling from the plasma membrane (4). Inhibition of Protein kinases C (PKCs) mediated internalization of transporters from plasma membrane (5).